UC Santa Cruz Genomics Institute

What UC Santa Cruz Genomics Institute does

The UC Santa Cruz Genomics Institute is a multidisciplinary academic research institute within the University of California, Santa Cruz, focused on genomics research and its applications to human health, conservation, and public health. Founded circa 2000 alongside the completion of the Human Genome Project, the institute's flagship product is the UCSC Genome Browser, a globally used genomic data visualization and analysis platform now in its 25th year. The institute integrates engineering, physical sciences, biological sciences, and social sciences, and maintains training programs for undergraduates, graduate students, and post-docs alongside diversity initiatives targeting Hispanic and first-generation college students.

The institute operates the Colligan Clinical Diagnostic Laboratory, licensed in March 2025, to provide specialized genomic analysis for pediatric patients with hard-to-treat cancers, and is developing RNA liquid biopsy technology for cancer early detection in partnership with Oxford Nanopore Technologies. Additional industry collaborations include de-extinction and conservation genomics work with Colossal Biosciences. Core technology assets include high-performance computing facilities, the Genome Browser platform, and clinical laboratory capabilities, with research outputs distributed openly to the global research community.

The institute does not operate a commercial product business. As an academic unit of the University of California system, funding derives from federal and state research grants, industry partnerships, donations, and institutional support; tools and data are distributed through open-access platforms, academic publications, and clinical laboratory services. Customer segments include academic and research institutions, healthcare and clinical organizations, conservation and environmental organizations, and public health agencies, with a global footprint spanning millions of researchers.

Name

UC Santa Cruz Genomics Institute

Legal name

UC Santa Cruz Genomics Institute

Website

https://ucscgenomics.soe.ucsc.edu

Company type

Private

Founded year

2000

Operating status

Operating

Short description

The UC Santa Cruz Genomics Institute is a multidisciplinary academic research unit within UC Santa Cruz that operates the UCSC Genome Browser, the Colligan Clinical Diagnostic Laboratory for pediatric cancer genomics, and RNA liquid biopsy research in partnership with Oxford Nanopore Technologies. It serves global academic, clinical, conservation, and public health communities through open-access genomics tools and training programs.

Ownership category

akta.pro rank

Product category

Genomics Research & Bioinformatics

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

Keywords

• Genomics research
• Genome browser
• Clinical diagnostics
• Computational biology
• Precision oncology

Headquarters

HQ city

Santa Cruz

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Distribution channels4 records

Marketing channels9 records

Core offering

The UC Santa Cruz Genomics Institute conducts and disseminates genomics research, anchored by the UCSC Genome Browser, an open-access genomic data visualization platform used by researchers worldwide. It also operates the Colligan Clinical Diagnostic Laboratory, providing specialized genomic analysis for pediatric cancer patients, and develops RNA liquid biopsy technology in partnership with Oxford Nanopore for non-invasive cancer detection.

Product overview

UC Santa Cruz Genomics Institute is a multidisciplinary research institute focused on genomics research and applications. The core product is the UCSC Genome Browser, a widely-used genomic visualization and analysis platform celebrating 25 years of operation. The institute also operates the Colligan Clinical Diagnostic Laboratory providing pediatric cancer diagnostic services, and offers various research collaborations, training programs, and computing facilities. The institute functions as an academic research organization rather than a commercial product company.

Differentiator

Problem solved

Functional benefit

Products and services

• UCSC Genome Browser A widely-used genomic data visualization and browsing tool that allows researchers worldwide to view and analyze genomic sequences, annotations, and research data. It is freely available through open-access web platforms and serves academic and clinical researchers globally.
• Colligan Clinical Diagnostic Laboratory A clinical diagnostic laboratory providing specialized genomic analysis for children with hard-to-treat cancers. The service delivers precision diagnosis and treatment guidance to healthcare providers and pediatric oncology patients.

Quantifiable outcome

• The Colligan Clinical Diagnostic Laboratory aims to offer specialized pediatric cancer analysis to every pediatric patient within the next ten years

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Oxford Nanopore TechnologiescoreTechnology or Integration · 1 June 2026Partnership to support development of RNA liquid biopsy technology for cancer early detection. The technology screens for cancer and abnormal precancerous cells using a simple blood draw, representing a significant advancement in non-invasive cancer detection methods.
• Braingeneers GroupminorStrategic or Co-development Partner · 1 June 2026Stem cell education platform that positively impacts Hispanic and first-generation college students, strengthening students' identity as scientists through technology and mentorship.
• Colligan Clinical Diagnostic LaboratorycoreStrategic or Co-development Partner · 1 March 2025Newly licensed pediatric cancer diagnostic laboratory providing specialized genomic analysis for children with hard-to-treat cancers. Led by Professor Olena Vaske, the lab aims to make advanced cancer analysis available to every pediatric patient within ten years.
• Colossal BiosciencesminorStrategic or Co-development PartnerCollaboration with the biotech company co-founded by Beth Shapiro focused on de-extinction research and applications of genomics to conservation efforts.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Broad Institute of MIT and Harvard: Major academic genomics and biomedical research institute operating genome-scale data platforms (e.g., GATK, gnomAD) and clinical programs. Directly comparable to UC Santa Cruz Genomics Institute as a multi-disciplinary research organization producing widely used open genomic data infrastructure.
• Wellcome Sanger Institute: UK-based genomic research institute with large-scale sequencing capabilities, open data resources, and translational research programs. Comparable as a foundational academic genomics institute producing reference data and tools used globally.
• European Bioinformatics Institute (EMBL-EBI): Operates large-scale open-access bioinformatics databases (Ensembl, ENA, UniProt) and genomic data infrastructure. Directly comparable to the UCSC Genome Browser as a global provider of open genomic reference data services.
• New York Genome Center: Academic genomics research center combining large-scale sequencing, computational biology, and clinical collaboration with New York-area medical institutions. Closely comparable in operating model to UC Santa Cruz Genomics Institute with research, clinical translation, and tool development.
• Jackson Laboratory for Genomic Medicine: Nonprofit biomedical research institute focused on mammalian genetics and genomic medicine with clinical sequencing services. Comparable as a nonprofit genomics research organization with clinical diagnostic capabilities and translational research programs.
• Baylor College of Medicine Human Genome Sequencing Center: Major academic sequencing center producing large-scale genomic data, clinical sequencing, and rare disease diagnostics. Comparable in role as an academic sequencing and clinical genomics provider to research consortia and healthcare systems.

Others

• National Human Genome Research Institute (NHGRI):

Broad incumbents

• Illumina: Dominant commercial provider of next-generation sequencing instruments and consumables used across academic and clinical genomics. Relevant as the broad incumbent whose sequencing platforms underpin much of the academic genomics work, including at the UC Santa Cruz Genomics Institute.

Emerging players

• Regeneron Genetics Center: Industry-led large-scale human genomics effort embedded within a pharmaceutical company, focused on sequencing-linked drug discovery and clinical insights. Comparable as a model combining academic-style large-scale genomics with clinical and commercial translation.

Regional players

• Genome Institute of Singapore (A*STAR GIS): Singapore-based national genomics institute conducting large-scale population and clinical genomics research. Comparable in mission and structure as a national-level academic genomics institute, though operating primarily in Asia rather than the US.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ucscgenomics
• YouTubeyoutube.com/channel/UC2Y3VtGdzR6ZPYUijCY84pQ
• Facebookfacebook.com/UCSCGenomicsInstitute
• LinkedInlinkedin.com/company/ucsc-genomics-institute
• Instagraminstagram.com/ucscgenomicsinstitute/?hl=en

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UC Santa Cruz Genomics Institute